RaySearch Laboratories AB (publ) Interim Report January 1 - June 30, 2010 JANUARY 1 - JUNE 30, 2010 · Net sales for the period totaled SEK 60.9 M (34.7) · Operating profit totaled SEK 23.8 M (16.6) · Profit after tax amounted to SEK 17.4 M (12.3), corresponding to earnings per share of SEK 0.51 (0.36) · Cash flow amounted to SEK 2.1 M (1.8) · RaySearch received FDA 510(k) clearance for RayStation® in the US in March · The collaboration agreement with Varian was expanded in April “The first half of 2010 was an outstanding period for RaySearch. The number of licenses sold more than doubled and revenues rose 76 percent to SEK 60.9 M, despite the negative impact of currency effects during the period,” says Johan Löf, CEO of RaySearch. “On June 19 we celebrated RaySearch's tenth birthday and I am pleased to be able to say that the company is currently doing better than ever”, concludes Johan Löf. For additional information, contact: Johan Löf, President Telephone: +46 (0)8-545 061 30 Johan.lof@raysearchlabs.com (Johan.lof@raysearchlabs.com)
RaySearch Laboratories AB (publ) Interim Report January 1 - June 30, 2010
| Source: RaySearch Laboratories AB